You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CHLORPROMAZINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for chlorpromazine and what is the scope of freedom to operate?

Chlorpromazine is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Actavis Mid Atlantic, Genus, Pharm Assoc, Wockhardt, Hikma, Fosun Pharma, Abraxis Pharm, Deva Hlding, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Marsam Pharms Llc, Watson Labs, Wyeth Ayerst, Zydus Pharms, Alpharma Us Pharms, Chartwell Rx, Abbott, Alembic, Amneal Pharms Co, Appco, Cycle, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lannett Co Inc, Lederle, Lupin, MSN, Purepac Pharm, Pvt Form, Sun Pharm, Teva Pharms, Upsher Smith Labs, Vangard, West Ward, Zydus Lifesciences, and Parke Davis, and is included in seventy-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for chlorpromazine.

Summary for CHLORPROMAZINE
US Patents:0
Tradenames:5
Applicants:39
NDAs:79
Drug Master File Entries: 24
Raw Ingredient (Bulk) Api Vendors: 74
Clinical Trials: 37
Patent Applications: 6,969
Drug Prices: Drug price trends for CHLORPROMAZINE
What excipients (inactive ingredients) are in CHLORPROMAZINE?CHLORPROMAZINE excipients list
DailyMed Link:CHLORPROMAZINE at DailyMed
Drug Prices for CHLORPROMAZINE

See drug prices for CHLORPROMAZINE

Recent Clinical Trials for CHLORPROMAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cancer Prevention Research Institute of TexasPhase 2/Phase 3
Sadat City UniversityPhase 1/Phase 2
Varun Monga, MDPhase 1

See all CHLORPROMAZINE clinical trials

Medical Subject Heading (MeSH) Categories for CHLORPROMAZINE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPROMAZINE

US Patents and Regulatory Information for CHLORPROMAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vangard CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 087645-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline THORAZINE chlorpromazine hydrochloride TABLET;ORAL 009149-020 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Genus CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride CONCENTRATE;ORAL 214542-002 Jun 2, 2021 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.